About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Successful Cessation of Progression of Hepatocellular Carcinoma with Everolimus Therapy

ventolin over the counter nsw

ventolin dosage
S.M Karandikar
From the Cancer Centre, Ruby Hall Clinic, Sassoon Road, Pune, Maharashtra-40, India.
Corresponding Author:
Dr. S.M Karandikar
Email: rarebrain46@gmail.com
Received: 03-JUN-2014 Accepted: 29-JUN-2014 Published Online: 25-JUL-2014
DOI: http://dx.doi.org/10.17659/01.2014.0067
Abstract
Management of advanced, unresectable hepatocellular carcinoma patients largely rely upon systemic therapy. Considering poor tolerability of sorafenib and promising role of mTOR inhibitors, everolimus could be a potential therapeutic option. A 65 year old, female patient was diagnosed with advanced hepatocellular carcinoma, ineligible to surgery or transplant. Therapy was started with sorafenib but withdrawn due to dermal toxicity. The patient was switched to everolimus which was continued for 17 months. Everolimus was well tolerated and inhibited the disease progression effectively. At follow up patient demonstrated stable disease with no increase in number or size of the cancerous nodules since diagnosis. 
Keywords : Hepatocellular carcinoma, Liver Neoplasms, Astrocytoma, Prognosis, Disease Progression.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share